Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 1 Study To Assess The Safety And Efficacy Of OCU200 For Center-Involved Diabetic Macular Edema

NCT05802329 is registered in ClinicalTrials.gov with Ocugen as lead sponsor.

NCT NCT05802329
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05802329 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 1 Study To Assess The Safety And Efficacy Of OCU200 For Center-Involved Diabetic Macular Edema
Lead sponsor
Ocugen
Phase
Phase 1
Overall status
Recruiting
Start date
January 13, 2024
Completion date
July 31, 2026
Enrollment
24 (estimated)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

center involved diabetic macular edema, diabetic macular edema